Publicacións en colaboración con investigadores/as de Harvard University (1)

2022

  1. MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma

    Virchows Archiv, Vol. 480, Núm. 4, pp. 855-871